共 46 条
- [1] Bundtzen RW(1981)Postantibiotic suppression of bacterial growth Rev Infect Dis 3 28-37
- [2] Gerber AU(1998)Pharmacokinetic/pharmacodynamic parameters: the rational for antibacterial dosing in mice and men Clin Infect Dis 26 1-10
- [3] Cohn DL(2000)Comparative in vitro activity and post-antibiotic effect of gemifloxacin against J Antimicrob Chemother 45 41-46
- [4] Craig WA(1995) spp. Clin Infect Dis 21 265-276
- [5] Craig WA(1996)Antimicrobial chemotherapy for Legionnaires’ disease Antimicrob Agents Chemother 40 314-19
- [6] Dubois J(1991)Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with Antimicrob Agents Chemother 35 399-405
- [7] St-Pierre C(2001) pneumonia Int J Antimicrob Agents 18 49-54
- [8] Edelstein PH(1981)Once-daily aminoglycoside therapy J Exp Med 153 398-406
- [9] Edelstein PH(2000)Comparative J Antimicrob Chemother 46 385-390
- [10] Edelstein MA(1989) bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of J Antimicrob Chemother 23 37-41